You can email us at, or call us on 01202 539791.Email: Phone: 01202 539791.


Imatinib, Free Base

Imatinib, marketed by Novartis as Gleevec or Glivec, investigational name STI-571, is a tyrosine-kinase inhibitor used in the treatment of multiple cancers, most notably Philadelphia chromosome-positive chronic myelogenous leukemia.

Product Details

Category Cancer Research and Antivirals
Price POA
CAS Number 152459-95-5
Formula C29H31N7O
Molecular Weight 493.60
Purity 99%
Appearance off white solid
Availability In Stock
Storage Conditions -18°C

Product Enquiry

Send us your enquiry for Imatinib, Free Base. We offer custom pack sizes at special prices. We aim to respond to your enquiry within 24 hours.

We value your input so if you have suggestions regarding new applications for Imatinib, Free Base email us and we will include your contribution on the website.

Enquire about product

Back to Top